SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-023225
Filing Date
2020-12-10
Accepted
2020-12-10 06:05:49
Documents
6
Period of Report
2020-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29126
2 ex99-1.htm EX-99.1 36210
3 ex99-1_001.jpg GRAPHIC 235912
4 ex99-1_003.jpg GRAPHIC 27062
5 ex99-1_004.jpg GRAPHIC 87600
6 ex99-1_005.jpg GRAPHIC 37328
  Complete submission text file 0001493152-20-023225.txt   601022
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 201379350
SIC: 2834 Pharmaceutical Preparations